Page 125 - WYSS2022 总结册-1
P. 125

围绕“人工智能对医疗健康产业带来的机遇与挑战”的话题,中国工程院院士樊代明、
                                                                                                                                                                     郑裕国、张英泽,中国科学院院士邓子新、骆清铭,武汉协和医院院长胡豫,北京协
                                                                                                                                                                     和医学院医学实验动物研究所所长秦川,国药集团总工程师、首席科学家杨晓明,迈
                                                                                                                                                                     博太科集团董事长郭亚军,中国金融策略投资控股有限公司董事长华风茂,达晨财智
                                                                                                                                                                     合伙人窦勇以及北京深势科技有限公司法人代表孙伟杰共同展开高峰对话。






                                                                                                                                                                     A high-level dialogue was held under the theme of “Opportunities and Challenges
                                                                                                                                                                     Brought by AI to the Medical and Health Industry”. The participants included Daiming
                                                                                                                                                                     Fan, Yuguo Zheng and Yingze Zhang, Academicians of the Chinese Academy of
                                                                                                                                                                     Engineering, Zixin Deng and Qingming Luo, Academicians of the Chinese Academy
                                                                                                                                                                     of Sciences, President Yu Hu of Wuhan Union Hospital, Chuan Qin, Director of the
                                                                                                                                                                     Institute of Laboratory Animal Sciences, CAMS & PUMC, Xiaoming Yang, Chief
                                                                                                                                                                     Engineer and Chief Scientist of Sinopharm Group, Chairman Yajun Guo of Taizhou
                                                                                                                                                                     Mabtech Group, Chairman Fengmao Hua of China Finance Strategies Investment
                                                                                                                                                                     Holdings Limited, Yong Dou, partner of Fortune Capital, and Weijie Sun, Legal Person
                                                                                                                                                                     of DPTechnology.








                                                                                                                                                                                                                                     123
   120   121   122   123   124   125   126   127   128   129   130